Leigh MacMillan Archive
-
March 25, 2025
C. diff uses toxic compound to fuel growth advantage
The findings of a new research study increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies aimed at a pathogen that causes about half a million infections in the U.S. each year. -
March 20, 2025
Primary Care Autism Team honored for developing new care pathway
“This program dramatically improved continuity of care, implementation of best practices, and patient/provider education.” -
March 14, 2025
Blood formation and disorders expert Stuart Orkin to present Discovery Lecture March 27
Orkin's research led to a gene therapy for sickle cell disease and beta-thalassemia; it is the first Food and Drug Administration-approved CRISPR-based gene therapy. -
March 12, 2025
Potential therapeutic for Duchenne muscular dystrophy takes step forward
Positive findings from a clinical trial support further study of the investigational drug ifetroban to treat cardiac complications, the leading cause of death in patients with DMD. -
March 10, 2025
VUMC to develop AI technology for therapeutic antibody discovery
The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest. -
February 3, 2025
Digital pathology aims to unlock secrets hidden in tissue samples
The pilot project, which is expected to digitize 500,000 slides over three years, aims to open avenues for research, assist with access to whole-slide images for education and clinical meetings (of tumor boards, for example), and facilitate planning for the implementation of digital pathology for diagnostic purposes.